Congenital Plasminogen Deficiency: Clinical Trials

2 trials for Congenital Plasminogen Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2

Follow Congenital Plasminogen Deficiency: new trials by email Literature Review of Congenital Plasminogen Deficiency trials Research Report on Congenital Plasminogen Deficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia
Plasminogen (Human) intravenous - Hypoplasminogenemia, Congenital Plasminogen Deficiency
Phase 2 / Phase 3CompletedPrometic Biotherapeutics, Inc.152016-05-042021-08-02
Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Human Plasminogen - Ligneous Conjunctivitis
Phase 2 / Phase 3CompletedKedrion S.p.A.122013-05-222023-01-25

Narrower conditions

Plasminogen Deficiency, Type I (1)

Interventions

Plasminogen (2)

Sponsors

Kedrion S.p.A. (1)  ·  Prometic Biotherapeutics, Inc. (1)

Countries

United States (2)  ·  Italy (1)  ·  Norway (1)

Top investigators

Amy Shapiro, MD (1)

Results publications

PMID 35346720, PMID 37674358, PMID 42226455, PMID 42528055